 |
市場調査レポート
世界のアフェレーシス市場：用途、タイプ、技術、地域別 - 成長、動向、予測Apheresis Market - Growth, Trends, and Forecast (2019 - 2024) |
||||||
| 発行 | Mordor Intelligence LLP | 商品コード | 390877 | ||||
| 出版日 | ページ情報 | 英文 118 Pages 納期: 2-3営業日 |
|||||
| 価格 |
|
||||||
| 世界のアフェレーシス市場：用途、タイプ、技術、地域別 - 成長、動向、予測 Apheresis Market - Growth, Trends, and Forecast (2019 - 2024) | ||
| 出版日: 2019年02月01日 | ページ情報: 英文 118 Pages |
|
アフェレーシスは、多様な疾患の緊急治療法として受け入れられており、何百万人もの患者が毎年アフェレーシス療法を受けています。今日、アフェレーシス療法は、関節リウマチ、癌、多発性硬化症などの慢性疾患に対する治療法のひとつとして認識されています。世界のアフェレーシス市場は、調査期間の2018年から2023年にかけて約7.7%のCAGRで推移することが予測されています。
当レポートでは、世界のアフェレーシス市場を調査し、市場の概要、用途・タイプ・技術・地域別の市場動向、市場規模の推移と予測、成長要因・阻害要因ならびに市場機会・課題の予測、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。
The propelling factors for the growth of the apheresis market include the increasing number of diseases, a rise in the demand for blood components and associated safety, technological advancement in the development of new apheresis techniques, and rise in the reimbursement policies and funding for apheresis procedures. Due to the aforementioned factors, the apheresis market is expected to experience a boost during the forecast period.
With the increasing number of surgeries and surgical techniques, advanced treatments have led to global demand for blood and the blood components. The need for blood components is significantly growing and contributing to healthcare spending. Apheresis has also recently witnessed a high demand due to an increased number of patients suffering from various ailments related to blood, kidney, metabolic diseases, and neurological disorders. Therefore, apheresis technology is used to reduce the number of white cells, until other medications can control them. With the steady increase in the number of patients suffering from these diseases, ailments, and the technical ease of using these devices in the treatment of these diseases, requiring a minimal hospital stay, the global apheresis market is poised to experience growth during the forecast period.
The use of apheresis in clinically ill patients is increasing day by day, and it has been widely used as the primary therapy or as an adjunct to other treatments for various diseases, such as thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, drug toxicities, autoimmune disease, sepsis, and fulminant hepatic failure.
Therefore with the steady increase in the number of patients suffering from these diseases, ailments, and the technical ease of using these devices in the treatment of these diseases, thus requiring a minimal hospital stay, the global apheresis market is poised to experience growth during the forecast period.
The Scope of the Report
As per the scope of the report, apheresis is a medical technique where the blood of an individual, be a donor or a patient, is passed through an apparatus that segregates out a particular constituent and returns the rest to the blood circulation. It involves blood purification and blood component separation by using centrifugation or membrane filtration technology. This procedure is performed for blood donation component or for the treatment of disease.
Hematological Disorders is the Segment under Application that is Expected to Grow Fastest during the Forecast Period
Hematological disorders are found common in low-income countries, and they make a substantial contribution to morbidity and mortality of individuals in these regions. Hence, owing to the increasing burden of hematological incidences and growing applications of apheresis as a treatment method for hematological disorders, the apheresis market for hematological disorders is expected to experience growth in the forecast period.
The recent years brought about a rise in new options of therapeutic apheresis, such as immunoadsorption, double filtration and cytapheresis used in the treatment of both primary and secondary autoimmune renal diseases. Those methods, more selective and safer than the classic TA, are potentially more efficient in the removal of pathogens, thus reducing the intoxication of the patient's organism.
Asia-Pacific holds the Fastest Growth and is Expected to follow the Same Trend over the Forecast Period
The Asia-Pacific region is predicted to witness high growth, owing to the rising geriatric population and the increasing prevalence of several choric diseases. China is found to be one of the largest consumers and manufacturers in the global plasma-derived products market and serves a vast population. Great progress has been made in the Chinese plasma fractionation industry in the past 50 years. Moreover, increasing healthcare expenditure is another critical factor that is likely to enhance the growth of the market in the near future.
The market studied is dominated by a few major players, and currently, the market is well established in many areas and has shown nascent success history. However, its full potential is yet to be determined in the developing regions. With increasing government initiatives, there is an awareness among people, which is further driving the growth of the market studied.
